CALCITONIN-SALMON (calcitonin salmon) by Sagent Pharmaceuticals is agonist. Approved for postmenopausal osteoporosis in women greater than 5 years postmenopause, osteoporosis, osteoporosis. First approved in 2008.
Drug data last refreshed 19h ago
agonist. Calcitonin salmon acts primarily on bone, but direct renal effects and actions on the gastrointestinal tract are also recognized. Calcitonin salmon appears to have actions essentially identical to calcitonins of mammalian origin, but its potency per mg is greater and it has a longer…
Calcitonin
Worked on CALCITONIN-SALMON at Sagent Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.